Concepedia

Carrie Cartwright

CC

Statistics

Publications

21

Citations

1.2K

H-Index

17

Active since

2004

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Sarah Cannon

The University of Texas Health Science Center at Houston

Foundation Medicine (United States)

Novartis (United States)

Carrie Cartwright is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, oncology, and molecular oncology.

Publications per year

2004–2025

21

Publications

21

Initiative for Molecular Profiling and Advanced Cancer Therapy (IMPACT): An MD Anderson Precision Medicine Study

Apostolia M. Tsimberidou, David S. Hong, Yang Ye et al. · JCO Precision Oncology · 2017 · 161 citations

, , +17

Autophagic Cell Death of Human Pancreatic Tumor Cells Mediated by Oleandrin, a Lipid-Soluble Cardiac Glycoside

Robert A. Newman, Yasuko Kondo, Tomohisa Yokoyama et al. · Integrative Cancer Therapies · 2007 · 138 citations · Full text

, , +16

Formation and antiproliferative effect of prostaglandin E3 from eicosapentaenoic acid in human lung cancer cells

Peiying Yang, Diana Chan, Edward Felix et al. · Journal of Lipid Research · 2004 · 114 citations · Full text

, , +13

Oleandrin-mediated inhibition of human tumor cell proliferation: Importance of Na,K-ATPase α subunits as drug targets

Peiying Yang, David G. Menter, Carrie Cartwright et al. · Molecular Cancer Therapeutics · 2009 · 87 citations

, , +13

Oleandrin-mediated oxidative stress in human melanoma cells.

Robert A. Newman, Peiying Yang, Walter N. Hittelman et al. · PubMed · 2006 · 83 citations

, , +17

1–5 of 21